ABSTRACT
No disponible
Subject(s)
Humans , Male , Child , Retroperitoneal Neoplasms/complications , Shock, Cardiogenic/etiology , Paraganglioma/complications , Tomography, X-Ray Computed , Retroperitoneal Neoplasms/diagnosis , Paraganglioma/diagnosis , Radionuclide ImagingABSTRACT
No disponible
Subject(s)
Humans , Male , Middle Aged , Adenocarcinoma/pathology , Adenocarcinoma/surgery , Esophageal Neoplasms/pathology , Esophageal Neoplasms/surgery , Esophageal Stenosis/diagnostic imaging , Esophageal Perforation/diagnostic imaging , Neoplasm Staging , Tomography, X-Ray Computed , EndoscopyABSTRACT
The management and prognosis of benign esophageal strictures differ from those of malignant strictures. Distinguishing between the two entities may occasionally be challenging, despite endoscopy and biopsies. The consequences of erroneous treatment may be fatal. We review this topic in a patient who required an emergency esophagectomy following a perforation after dilation due to a peptic stricture, which concealed an esophageal cancer.
Subject(s)
Esophageal Neoplasms , Esophageal Perforation , Esophageal Stenosis , Constriction, Pathologic , Dilatation , Esophageal Neoplasms/complications , Esophageal Neoplasms/surgery , Esophageal Perforation/diagnostic imaging , Esophageal Perforation/etiology , Esophageal Perforation/surgery , Esophageal Stenosis/diagnostic imaging , Esophageal Stenosis/etiology , Esophageal Stenosis/surgery , Humans , Neoplasm Recurrence, LocalSubject(s)
Paraganglioma/complications , Retroperitoneal Neoplasms/pathology , Shock, Cardiogenic/etiology , Adolescent , Adrenergic alpha-1 Receptor Antagonists/administration & dosage , Adrenergic alpha-1 Receptor Antagonists/therapeutic use , Doxazosin/administration & dosage , Doxazosin/therapeutic use , Drug Therapy, Combination , Extracorporeal Membrane Oxygenation/methods , Humans , Labetalol/administration & dosage , Labetalol/therapeutic use , Male , Paraganglioma/drug therapy , Paraganglioma/surgery , Preoperative Care , Recurrence , Retroperitoneal Neoplasms/diagnostic imaging , Shock, Cardiogenic/diagnosis , Shock, Cardiogenic/therapy , Tomography, X-Ray Computed/methods , Treatment OutcomeABSTRACT
BACKGROUND: Despite increases in knowledge and advances in the management of acute mesenteric ischemia syndrome (AMI), there have been no significant improvements in mortality in recent years. The objective of this study was to assess the changes in clinical characteristics and surgical outcomes in patients who underwent AMI over time. METHODS: A total of 323 consecutive patients who underwent acute mesenteric ischemia at our institution between 1990 and 2015 were examined. The occurrence of significant changes over this 25-year period in demographic data, comorbidity, clinical characteristics, laboratory results, operative findings, etiology of the AMI, and operative mortality were evaluated. The evolution mortality rates for the studied period were analyzed using the additive logistic regression, and the significant effect was determined using the Akaike Information Criterion (AIC). RESULTS: A significant increasing linear trend was observed in recent years in Charlson score values (p = 0.008), antiplatelet drug intake (p < 0.001), use of CT scan (p < 0.001), arterial thrombosis (p < 0.001), and intestinal resection (p = 0.047), while a decreasing linear trend was observed in digoxin intake (p < 0.001), angiography use (p = 0.004), and embolia (p < 0.001). The rest of the parameters did not present changes over time. Regarding the evolution of the adjusted surgical mortality, a significant decrease according the AIC criterion was observed. CONCLUSIONS: In recent years, the characteristics of patients with AMI requiring surgery have changed. Changes in operative mortality have also been detected, showing a tendency toward a progressive and significant decrease.
Subject(s)
Mesenteric Ischemia/surgery , Acute Disease , Aged , Aged, 80 and over , Female , Humans , Logistic Models , Male , Mesenteric Ischemia/mortality , Middle AgedABSTRACT
No disponible
Subject(s)
Humans , Surgical Procedures, Operative/methods , Aerosols/administration & dosage , Carcinoma/drug therapy , Abdominal Cavity/surgery , Peritoneal Neoplasms/drug therapy , Peritoneal Neoplasms/pathology , Carcinoma/therapySubject(s)
Aerosols/administration & dosage , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Carcinoma/drug therapy , Peritoneal Neoplasms/drug therapy , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Carcinoma/pathology , Carcinoma/secondary , Combined Modality Therapy/methods , Cytoreduction Surgical Procedures/methods , Female , Hospitals, Public , Humans , Hyperthermia, Induced/methods , Middle Aged , Neoplasm Metastasis/pathology , Ovarian Neoplasms/complications , Ovarian Neoplasms/pathology , Peritoneal Neoplasms/pathology , Peritoneal Neoplasms/secondary , Quality of Life , Spain/epidemiology , Treatment OutcomeABSTRACT
No disponible